During the past decade, Southern Therapy and Advanced Research conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 5 clinical trials were completed, i.e. on average, 17.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 4 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Therapy and Advanced Research" #1 sponsor was "Intercept Pharmaceuticals" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Madrigal Pharmaceuticals, Inc." with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Therapy and Advanced Research" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Novo Nordisk A/S" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "University of North Carolina, Chapel Hill" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Southern Therapy and Advanced Research" are "Crohn Disease" (3 trials), "Nonalcoholic Steatohepatitis" (3 trials), "Crohn's Disease" (2 trials), "Hepatitis C" (2 trials) and "Non Alcoholic Steatohepatitis (NASH)" (2 trials). Many other conditions were trialed in "Southern Therapy and Advanced Research" in a lesser frequency.

Most popular intervention types in "Southern Therapy and Advanced Research" are "Drug" (24 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Ozanimod" (3 trials), "Resmetirom" (2 trials), "AXA1125" (1 trials) and "AXA1957" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Therapy and Advanced Research" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Southern Therapy and Advanced Research". undefined are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Southern Therapy and Advanced Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Therapy and Advanced Research, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".